Chemiesynth Board Approves Share Capital Hike, NCRPS Issuance

Chemiesynth (Vapi) Ltd's Board of Directors met on August 12, 2026, approving the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report. A significant decision was the approval to increase the authorized share capital from ₹3.25 Crores to ₹18.25 Crores, comprising equity and preference shares. The board also greenlit the private placement issuance of up to ₹15 Crores in Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) with a 5% annual dividend. The 40th Annual General Meeting is scheduled for September 30, 2026.